CAS 2117405-13-5

Formula: C18H19FN6

InChI: InChI=1S/C18H19FN6/c1-24-12-22-23-17(24)13-6-9-25(10-7-13)18-15(3-2-8-20-18)14-4-5-16(19)21-11-14/h2-5,8,11-13H,6-7,9-10H2,1H3

InChI key: AJIAMIPUWJQSPR-UHFFFAOYSA-N

SMILES: CN1C=NN=C1C2CCN(CC2)C3=C(C=CC=N3)C4=CN=C(C=C4)F

3-(6-Fluoropyridin-3-yl)-2-[4-(4-methyl-4H-1,2,4-triazol-3-yl)piperidin-1-yl]pyridine

CAS: 2117405-13-5

3-(6-Fluoropyridin-3-yl)-2-[4-(4-methyl-4H-1,2,4-triazol-3-yl)piperidin-1-yl]pyridine

Formula: C₁₈H₁₉FN₆

Purity: 95%

Molecular weight: 338.39

Ref: 54-PC1007087

SEN177

CAS: 2117405-13-5

SEN177 glutaminyl cyclase inhibitor for neurodegenerative disease, protein aggregation, Huntington’s disease and QPCT/QPCTL pathway research.

Formula: C₁₈H₁₉FN₆

Purity: 99.37%

Color and Shape: Solid

Molecular weight: 338.3821

Ref: TM-T61063

6'-fluoro-2-[4-(4-methyl-4H-1,2,4-triazol-3-yl)piperidin-1-yl]-3,3'-bipyridine

CAS: 2117405-13-5

Formula: C₁₈H₁₉FN₆

Purity: 95%

Molecular weight: 338.3821

Ref: IN-DA01DX69

SEN177

CAS: 2117405-13-5

3-(6-Fluoropyridin-3-yl)-2-[4-(4-methyl-4H-1,2,4-triazol-3-yl)piperidin-1-yl]pyridine

Formula: C₁₈H₁₉FN₆

Purity: 95%

Molecular weight: 338.38

Ref: IN-DG01001484

SEN 177

CAS: 2117405-13-5

Inhibitor of glutaminyl cyclase QPCT

Formula: C₁₈H₁₉FN₆

Purity: Min. 95%

Molecular weight: 338.38 g/mol

Ref: 3D-BS170200